International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 263
- Publication type:
- Article
Works matching IS 10109609 AND DT 1999 AND VI 13 AND IP 4
Results: 27
1
2
Essential Drugs.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 249
- Publication type:
- Article
3
ATC/DDD Classification (final).
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 245
- Publication type:
- Article
4
ATC/DDD Classification (temporary).
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 242
- Publication type:
- Article
5
Rules for dietary supplements finalized.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 241
- Publication type:
- Article
6
Miralex®: undeclared corticosteroid.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 241
- Publication type:
- Article
7
V-King®: unapproved use of sildenafil.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 241
- Publication type:
- Article
8
Unapproved HIV test kits available on the internet.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 240
- Publication type:
- Article
9
Initiative to curb illegal sale of drugs over the internet.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 240
- Publication type:
- Article
10
Abacavir: hypersensitivity reactions.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 240
- Publication type:
- Article
11
Postmarketing system to be revised.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 240
- Publication type:
- Article
12
Reteplase incompatible with heparin.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 239
- Publication type:
- Article
13
Grepafloxacin withdrawal: severe cardiovascular events.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 239
- Publication type:
- Article
14
Methotrexate: care in prescribing.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 239
- Publication type:
- Article
15
Methotrexate: monitoring essential.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 239
- Publication type:
- Article
16
Levetiracetam: new drug for epilepsy.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 239
- Publication type:
- Article
17
Pemoline withdrawal following liver complications.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 238
- Publication type:
- Article
18
Sertraline for post-traumatic stress disorder.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 238
- Publication type:
- Article
19
Didanosine and pancreatitis.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 238
- Publication type:
- Article
20
Leflunomide: pancytopenia and skin reactions.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 238
- Publication type:
- Article
21
Thiomersal: theoretical risk leads to phasing out.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 237
- Publication type:
- Article
22
Influenza preparedness plan: vaccine production and availability.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 235
- Publication type:
- Article
23
Quality assurance and safety of biologicals.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 231
- Publication type:
- Article
24
Roll Back Malaria.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 228
- Publication type:
- Article
25
Atovaquone and proguanil hydrochloride: a new antimalarial combination.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 226
- Publication type:
- Article
26
Influenza preparedness plan: antiviral drugs.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 225
- Publication type:
- Article
27
WHO's role in ensuring access to essential drugs.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 4, p. 217
- Publication type:
- Article